Abstract | BACKGROUND: METHODS: The authors conducted a study of 65 mastectomized patients (age range, 34 to 62 years) who had received radiotherapy with a 6-MeV electron accelerator. In the first operation, they inserted the Natrelle 133-MV expander (Allergan, Inc., Irvine, Calif.) endoscopically under the pectoralis major at the end of the mastectomy scar and performed total immediate expansion. The authors injected a mean quantity of 150 +/- 25 cc of fat in the upper quadrants between the skin and the muscle and also inside the muscle. After 3 months, they removed the expander through the same incision, inserted the McGhan Style 410 cohesive silicone prosthesis, and injected a mean 150 +/- 30 cc of fat in the lower quadrants. In the third stage, the nipple-areola complex was reconstructed. RESULTS: Mean follow-up was 1 year, with controls after 1 week, 1 month, 3 months, and 12 months. No complications were recorded with the fat injections. Patients' mean satisfaction rating was 4 on a scale of 1 (low) to 5 (high), and the capsular contracture was never above 1 on the Baker classification. CONCLUSION: In mastectomized patients who received radiotherapy, fat grafting in addition to traditional tissue expander and implant breast reconstruction achieves better reconstructive outcomes with the creation of new subcutaneous tissue, accompanied by improved skin quality of the reconstructed breast without capsular contracture.
|
Authors | Jose Maria Serra-Renom, Juan Luis Muñoz-Olmo, Jose Maria Serra-Mestre |
Journal | Plastic and reconstructive surgery
(Plast Reconstr Surg)
Vol. 125
Issue 1
Pg. 12-18
(Jan 2010)
ISSN: 1529-4242 [Electronic] United States |
PMID | 20048576
(Publication Type: Journal Article)
|
Topics |
- Adipose Tissue
(transplantation)
- Adult
- Breast Implantation
- Breast Implants
- Breast Neoplasms
(radiotherapy, surgery)
- Combined Modality Therapy
- Female
- Humans
- Mammaplasty
(methods)
- Mastectomy
- Middle Aged
- Patient Satisfaction
- Reoperation
- Tissue Expansion Devices
|